Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to analyze the effectiveness/safety/cost of the Smart Homespital system that provides a service that allows patients with interstitial lung disease to easily access and use biosignals generated using biosignal collection medical equipment at home.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| intervention group | Experimental | The Smart Homespital system can be applied for the first 3 months (12 weeks), and then the primary and secondary variables will be evaluated at 3, 6, 9months. |
|
| attention-waitlist control group | Experimental | The waiting list-control group will receive general medical services for the first 3 months and will receive the Smart Homespital system for 3-6 months. Primary and secondary variables will be evaluated between 3, 6, and 9 months. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Immediate application of the Smart Homespital system | Behavioral | The Smart Homespital system can be applied for the first 3 months (12 weeks), and then the primary and secondary variables will be evaluated at 3, 6, 9months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| Respiratory symptom questionnaire | For survey scores, success is defined as an increase in the respective defined MCID(the minimal clinically important difference) rises the baseline. 1) Chronic respiratory questionnaire (CRQ)
| After applying the Smart Homespital system(12weaks) |
| Measure | Description | Time Frame |
|---|---|---|
| Depression Questionnaire | K-CESD-R : Survey every 2 weeks during the 12-week Homespital system application, then at 3, 6, and 9 months after the start of the study.
| Survey every 2 weeks during the 12-week Homespital system application, then at 3, 6, and 9 months after the start of the study. |
Not provided
Inclusion Criteria:
Patients diagnosed with COPD who meet the following pulmonary function test results:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Division of Pulmonary and Critical Care Medicine | Seoul | 03722 | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Delayed application of the Smart Homespital system after 3 months | Behavioral | The waiting list-control group will receive general medical services for the first 3 months and will receive a Smart Homespital system for 3-6 months. Primary and secondary variables will be monitored between 3, 6, and 9 months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks. |
|
| Service satisfaction evaluation |
| After 12 weeks of applying the Smart Homespital system. |
| safety |
| Measured after the study ends (9 months later). |
| cost assessment | - Criteria: Comparison of average hospital respiratory rehabilitation treatment costs with the Smart Homespital program's costs. | After study ends (9 months later) |
| 6 minute walking test | - Success Criteria: More than a 10% increase over the baseline. | At 3, 6, and 9 months. |
| pulmonary function test | - Success Criteria: Increase in FVC, FEV1, or DLCO by more than 10% at the time of registration. | At 3, 6, and 9 months. |
| system compliance | -Criteria: Maintaining a minimum of 5,000 steps/day during the 12-week period of applying the Homespital system. | During the 12-week period of applying the Homespital system. |
| ID | Term |
|---|---|
| D017563 | Lung Diseases, Interstitial |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided